Search

everythinglearnresearchcommunity

for

Search:↓

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Inner city teens had high retention rates for the contraceptive implant, especially those with a history of abortion.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

Treat pattern hair loss with finasteride and topical minoxidil.

The paper concludes that drug labels should be clear for all, especially for those with low literacy, and suggests aiming for high comprehension test passing rates with diverse test populations.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Many adults in Porto have acne, but few know or treat it.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.